Citadel Advisors’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,666
Closed -$15.4K 15708
2022
Q4
$15.4K Buy
3,666
+298
+9% +$1.4K ﹤0.01% 13330
2022
Q3
$18K Buy
3,368
+1,747
+108% +$33.3K ﹤0.01% 12119
2022
Q2
$91K Buy
1,621
+1,213
+297% +$66.3K ﹤0.01% 11502
2022
Q1
$24K Sell
408
-558
-58% -$28.4K ﹤0.01% 13198
2021
Q4
$67K Sell
966
-1,646
-63% -$127K ﹤0.01% 13075
2021
Q3
$187K Sell
2,612
-1,007
-28% -$78.6K ﹤0.01% 12083
2021
Q2
$303K Buy
+3,619
New +$274K ﹤0.01% 11248
2019
Q1
Sell
-451
Closed -$15K 10002
2018
Q4
$15K Sell
451
-83
-16% -$3.66K ﹤0.01% 8843
2018
Q3
$30K Buy
534
+83
+18% +$5.25K ﹤0.01% 8932
2018
Q2
$35K Sell
451
-988
-69% -$79.5K ﹤0.01% 8523
2018
Q1
$116K Buy
+1,439
New +$290K ﹤0.01% 7664
2017
Q2
Sell
-323
Closed -$62K 8202
2017
Q1
$62K Buy
+323
New +$62K ﹤0.01% 6995

Other funds holding NTBL

Citadel Advisors's NTBL Position: Q1 2023 in Review

Citadel Advisors sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q1 2023, closing a stake of 3,666 shares — an estimated $15.4K sold.

Citadel Advisors first reported a position in NTBL in Q1 2017 and held it in 12 quarters. The position peaked at $303K in Q2 2021. 18 funds tracked by Wall St. Rank hold NTBL as of Q1 2023.

  • Citadel Advisors reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 3,666 Notable Labs, Ltd. Ordinary Shares shares in Q1 2023, an estimated $15.4K.
  • Citadel Advisors first reported a position in Notable Labs, Ltd. Ordinary Shares in Q1 2017 and held it in 12 quarters.
  • Citadel Advisors's Notable Labs, Ltd. Ordinary Shares position peaked at $303K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.